Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.

Georgeson PSteinfelder RSHarrison TAPope BJZaidi SHQu CLin YJoo JEMahmood KClendenning MWalker RAglago EKBerndt SIBrenner HCampbell PTCao YChan ATChang-Claude JDimou NDoheny KFDrew DAFigueiredo JCFrench AJGallinger SGiannakis MGiles GGGoode ELGruber SBGsur AGunter MJHarlid SHoffmeister MHsu LHuang W-YHuyghe JRManson JEMoreno VMurphy NNassir RNewton CCNowak JAObón-Santacana MOgino SPai RKPapadimitrou NPotter JDSchoen RESong MSun WToland AETrinh QMTsilidis KUgai TUm CYMacrae FARosty CHudson TJWinship IMPhipps AIJenkins MAPeters UBuchanan DD2025-06-162025-06-162023-03-12https://mro.massey.ac.nz/handle/10179/73064(c) 2024 The Author/sCC BY-NC-ND 4.0https://creativecommons.org/licenses/by-nc-nd/4.0/colibactincolorectal cancermutational signaturespks+ E. coliGenotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.other10.1101/2023.03.10.23287127preprinthttps://www.ncbi.nlm.nih.gov/pubmed/37090539